Objective: This study was aimed at establishing the prevalence, sex, age, and site distribution of salivary gland neoplasms as seen in the Department of Oral Surgery Mulago Hospital Uganda.
Introduction
Different diseases affecting the salivary glands affect the efficiency and normal function of the glands. The diseases range from infections, inflammation, obstruction, functional disorders, and neoplasms. Although in the general population, the prevalence of salivary gland neoplasms is relatively low in relation to other salivary gland diseases, they do constitute a significant proportion of oral tumors after squamous cell carcinoma. 1 A study from Nigeria reports salivary gland neoplasms as 2.8% of all head and neck tumors. 2 In Kenya they are among the most common oral tumors. 3 While in Uganda, they ranked next to sarcomas, adamantinomas (ameloblastoma), and carcinomas. 4 Despite the fact that globally benign salivary gland tumors predominate over malignant ones [5] [6] [7] [8] [9] [10] , there is a variation in the prevalence of the specific salivary gland neoplasms from study to study worldwide. In the state of Oklahoma in the USA 5 , Jamaica 6 , and Japan
11
, muco-epidermoid carcinoma is the most prevalent malignant neoplasm, while in Britain 12 adenoid cystic carcinoma predominates. In South Africa 10 polymorphous low-grade adenocarcinoma predominates. The most afflicted sites by these tumors also vary from study to study. For example, pleomorphic adenoma is the most common tumor in the parotid gland. Seventy five percent of these tumors are present in the parotid gland as compared to 39.8% in the palate. 13 The situation in Uganda is not yet clearly known since we could only find one article 4 on this subject. Sing et al. reports of a palatal location but the findings are about tumors of the jaws which may have included pleomorphic adenoma of the minor salivary glands of the palate.
The sex distribution of these neoplasms is also reported differently by different authors. A report from Brazil 7 reports a slight female preponderance of minor salivary gland neoplasms, while the Jordanian study reports a slight male preponderance. 8 Cawson 1 reports salivary gland carcinoma preponderance for females, and Aritoba 14 reports several sex preponderancies of different salivary gland neoplasms in relation to their location. The age distribution of patients with salivary neoplasms differ. 10, 14, 15, 16 The purpose of this study was to establish the different biopsed and histopathologically confirmed salivary gland neoplasms seen at the Department of Oral Surgery Mulago Hospital, their age, sex distribution, and site for a period between January 1988 to December 2000.
Materials and Methods
A total of 142 salivary gland neoplasm reports were retrieved from the histopathological results files of the Department of Oral Surgery Mulago Hospital Kampala Uganda stretching from the year 1988-2000.
Clinical information including, age, sex, and site from which the biopsy was taken were recorded. The data was compiled manually onto a master sheet from which tallying was done. Both the t-test and z-test were used for data analysis.
We also went on to ask the pathologists for the criteria they use in the diagnosis of salivary gland tumors. A summary is provided in Table 1 .
Results
The distribution of the various salivary gland neoplasms is presented in Table 2 . They comprised 7.5% of all oral neoplasms. From the Department's biopsy results file, (77) 54.23% of the lesions were benign and (65) 45.77% were malignant.
Of all the benign lesions, the most frequent was pleomorphic adenoma constituting 77.9%, followed by salivary gland adenoma 18.18%, and then oxyphil cell adenoma at 3.9%. Among the malignant salivary gland neoplasms, adenocarcinoma was the most prevalent at 36.92%, followed by carcinoma at 27.69%, then muco-epidermoid carcinoma 9.23%, mucus secreting carcinoma constituted 6.15%, acinic cell carcinoma 4.62%, and carcinoma ex pleomorphic adenoma 3.08%. Of the 142 cases, 64 (45.07%) were male, 76 (53.52% were female, and in 2 cases (1.41%) sex was not specified. The male:female ratio was 1: 1.18. Forty-three (55.84%) of the benign neoplasms cases were female; while 33 (50.77%) of malignant cases were female and 2 (3.08%) of the malignant cases were unspecified. The gender distribution of these salivary gland neoplasms is shown in Table 2 , and the age distribution of these cases is shown in Table 3 . The mean age for this patient population was 33.83 ± 18.83 with an age range of 1-80 years. The mean age of the benign neoplasms was 26.74 ± 16.0, while that of the malignant neoplasms was 42.49 ± 9.15. Most cases were in the second, third, fourth, and fifth decade of life with a peak incidence in the third decade (see Table 3 and Figure 1 ).
The mean age of the most prevalent neoplasms, i.e., pleomorphic adenoma had a mean age of 29 ± 15.74 with a range of 5-69 years and a peak in the third decade of life ( Figure 1 ). The mean age of patients with salivary gland adenoma was 19.59 ± 1.73. Among the malignant salivary gland neoplasms, adenocarcinoma had a mean age of 47.17 ± 19.09, while adenoid cystic carcinoma had a mean of 40.56 ± 17.09; salivary duct carcinoma and mucoe-pidermoid carcinoma had a mean age of 46.8 ± 18.28 and 38 ± 18.74, respectively.
The distribution of each type of salivary gland neoplasms as per site of biopsy is shown in Table  4 . Of all the histopathological report slips, 47.1% did not have the site of biopsy specified. Among those whose site of biopsy was available, the palate and parotid area were the most common sites 49.33% and 26.67%, respectively. (See Table 3 and Figure 2 ). 2, 6, 8, 16, 19, 21 Although there have been some reports on salivary gland neoplasms as a component of tumors of the oral facial area from Uganda 4 , no specific report is available from this part of the world on salivary gland neoplasms independent from other classification of tumors.
Discusion
From Table 2 benign salivary gland neoplasms were more prevalent (54.3%), which is consistent with several other studies as can be seen in Table 5 . Similar to Neely et al. our study shows an almost equal prevalence of benign and malignant tumors. 5 In contrast, Williams et al. and
Vargas et al. reported significantly different prevalences, although benign lesions still predominate. 6, 16 Among the benign group and on the over all, pleomorphic adenoma was the most common salivary gland tumor. This agrees with previous studies (Table 5) and with more recent studies 6, 8, 14, 16, 21 , hence it seems the world over, Uganda inclusive, pleomorphic adenoma is the most common salivary gland tumor. Slide 6 shows one of the cases diagnosed as pleomorphic adenoma.
Among the benign group, salivary gland adenoma was the second most common diagnosis. Unfortunately while Cawson reports it 1 , this diagnosis does not exist in the World Health Organization (WHO) classification 20 but could be the equivalent of monomorphic adenomas inclusive of adenolymphomas, a diagnosis not seen in these studies or other types since at least three cases of oxyphilic adenoma are reported. It must be noted in the WHO classification 20 salivary gland adenoma comprises a group of fourteen tumors. The only subtype found in this study were pleomorphic adenoma (42.3%) and oxyphylic cell adenoma (onconcytoma) 2.1%; the remaining adenomas (9.9%) were not further classified. The pathologists helped us review some adenomas and we discovered that adenomas as diagnosed varied from cannalicular, warthin's tumor, to cystadenoma as can be seen in slides 3, 4, and 5; slide 6 shows pleomorphic adenoma. Hence,there is a need to review and standardize the diagnoses of the different patients' specimens seen in the Department of Pathology according to the current International Classification of Diseases (ICD)/World Health Organization (WHO) classification.
The results of our study are in agreement with the study done in South Africa 10 ; was found to be the most common salivary gland malignancy. However, other studies are in contrast with these findings 2, 5, 6, 7, 11, 12, 16 with some rarely reporting this tumor. 18, 19 Furthermore in this study some adenocarcinomas were not sub typed; yet on review, variations were clear as can be seen in slides 1 and 2 showing unspecified and acinic cell adenocarcinoma, respectively. Thus, a combined effort to review African studies is needed to establish whether this is an African phenomenon or just a regional one or whether reporting is standardized to a specific classification. Adenoid cystic carcinoma in this study was found to be the second most prevalent tumor followed by muco-epidermoid carcinoma at 27.69% and 12.31%, respectively. This is similar to a report from Nigeria, which ranks both as the most common salivary gland neoplasms. 2 Unlike the Jamaican and Brazilian studies 6, 16 , adenoid cystic carcinoma predominates over muco-epidermoid carcinoma in our study. In this study salivary gland carcinoma was the third most common lesion at 9.23%. This diagnosis is not reported in other studies as can be seen from Table 5 and is not a diagnosis cited in the WHO classification 20 further stressing the need for standardization of reporting. Mucus secreting carcinoma was reported in our study. As seen in Table 5 , some researchers, but not all, reported this category of Slides 1 and 2 show two different adenocarcinomas whose sub type was not specifi ed. However, on review they were sub typed as unspecifi ed and acinic cell adenocarcinoma, respectively. Slides 3, 4, and 5 were all diagnosed as adenomas, while slide 6 was diagnosed as pleomorphic adenoma. On review, slides 3, 4, and 5 were sub-typed as cannalicular, Warthin's tumor, and cyst adenoma. tumor. Cawson 1 argues this is likely to belong to the epidermoid tumor group and could be considered either benign or malignant. Acinic cell carcinoma constituted 4.6% of all salivary gland malignancy and 2.1% overall which is in agreement with other studies 1,17,18 as being a rare salivary gland neoplasm. Carcinoma ex pleomorphic constituted (2 cases) 1.4% overall and 3.08% of all malignant lesions. Unfortunately, the references available to us hardly mentioned this tumor. Cawson attributes its rarity to carcinomatous changes in pleomorphic adenoma occurring late, thus, rarely given a chance to get to this stage 1 . However, Lewis et al. 22 reports non specified adenocarcinoma as one of the sub-types of this tumor, and Varga et al. 16 also notes all the cases they saw had adenocarcinoma as the malignant component; it is unclear whether adenocarcinomas seen in this study might have been alternatively classified as carcinoma ex pleomorphic adenoma.
Of all cases in this study 53.5% were female, 45.1 were specified as male, and 1.4% were unspecified. Thus, an almost equal sex distribution (p=0.05) which is in agreement with several other studies. 2, 4, 5 The male to female ratio was 1:1.19, thus, no statistically significant difference in sex distribution. These statistics differ from those of Jordan 8 ; hence, the question of possible geographical differences in their prevalence. Both malignant and benign neoplasms had equal sex distribution (p=0.05). Pleomorphic adenoma had a slight preponderance for females with the male to female sex ratio being 1:1.3, which is in agreement with other findings. 13 Unlike a report from Nigeria 14 , for all age groups, female distribution predominated over males. Salivary gland adenoma had equal sex distribution, but because no other study we came across recognized this entity we had nothing to compare with. All of the three cases of oxyphil cell adenoma were female though Cawson 1 writes of a female preponderance; in this study we could not establish any sex preponderance due to the few cases found. Adenocarcinoma had equal sex distribution (p=0.05). However, for poorly differentiated adenocarcinoma, there was male preponderance over female (p=0.05). Adenoid cystic carcinoma had female preponderance over male (p=0.05). The numbers of salivary gland carcinoma, muco-epidermoid carcinoma, and acinic cell carcinoma were too few to comfortably establish sex preponderance. Carcinoma ex pleomorphic adenoma had only two cases, both being male.
The distribution of the salivary gland neoplasms as per site of biopsy is shown in Table  4 . Unfortunately, many of the biopsy sites in this study's cases 47.18% were not recorded. Of those recorded, the palate featured greatly constituting 45.94%, followed by the parotid area 26.67%, and sub-mandibular area 16% (Table  4 and Figure 2 ). These results agree with a few other studies from Africa. The palatal neoplasms had a preponderance for females 64.7% (p=0.005), a fact that was reported by Onyango et al. 21 The parotid region was equally affected by both malignant and benign tumors, which is in contrast with other reports 17, 18 , therefore, geographical differences may exist.
Though pleomorphic adenoma is known to mainly affect the parotid gland 1, 17 , in this study it affected the palate (p=0.05). The lip was affected in just three cases. Of the three lip lesions, two were malignant, i.e., adenoid cystic carcinoma and muco-epidermoid carcinoma with the third being salivary gland adenoma. Owens et al. 24 reports adenoid cystic carcinoma and muco-epidermoid carcinoma as the most frequent malignant salivary gland neoplasms of the lip.
As reported by other authors elsewhere, our results agree with the findings that pleomorphic adenoma is common among adults and in the fact salivary neoplasms appear in the third, fourth, and fifth decade of life with a peak in the third decade (Table 3 and Figure 1 ). Though not reflected in either the tables or figures, the general overall presentation between the sexes, in terms of age at the time of reporting, revealed there were many more females with pleomorphic adenoma than males in the peak group.
Conclusion
There are significant reporting differences by diagnosis and a lack of information regarding the sites of lesions.
There is a geographic variation in the prevalence of salivary gland neoplasms according to sex, age, and site. More research into specific salivary gland neoplasms inclusive of treatment modalities, prognosis, and causative factors are needed in Uganda.
While the objective of this study was to establish the prevalence and site distribution of salivary gland neoplasms as seen in the Department of Oral Surgery Mulago Hospital, we realize a need for standardization and improved reporting by both the surgeons and pathologists.
